Spire Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$342K Sell
5,931
-742
-11% -$42.6K 0.01% 639
2026
Q1
$405K Sell
6,673
-483
-7% -$28.2K 0.01% 593
2025
Q4
$386K Buy
7,156
+365
+5% +$17.6K 0.01% 606
2025
Q3
$306K Sell
6,791
-1,137
-14% -$53.1K 0.01% 664
2025
Q2
$367K Sell
7,928
-10,120
-56% -$497K 0.01% 583
2025
Q1
$1.1M Sell
18,048
-290
-2% -$16.9K 0.04% 384
2024
Q4
$1.04M Buy
18,338
+760
+4% +$42.5K 0.03% 383
2024
Q3
$909K Sell
17,578
-1,965
-10% -$92.2K 0.03% 390
2024
Q2
$812K Sell
19,543
-309
-2% -$13.8K 0.03% 387
2024
Q1
$1.08M Buy
19,852
+2,443
+14% +$124K 0.02% 361
2023
Q4
$872K Sell
17,409
-1,753
-9% -$92K 0.03% 395
2023
Q3
$1.11M Sell
19,162
-2,943
-13% -$180K 0.04% 310
2023
Q2
$1.41M Sell
22,105
-3,251
-13% -$218K 0.05% 281
2023
Q1
$1.76M Buy
25,356
+9,092
+56% +$641K 0.07% 244
2022
Q4
$1.17M Buy
16,264
+656
+4% +$49.5K 0.07% 216
2022
Q3
$1.11M Sell
15,608
-11,800
-43% -$856K 0.07% 199
2022
Q2
$2.11M Buy
27,408
+997
+4% +$75.9K 0.09% 206
2022
Q1
$1.93M Sell
26,411
-31,537
-54% -$2.12M 0.05% 286
2021
Q4
$3.61M Buy
57,948
+27,771
+92% +$1.63M 0.08% 209
2021
Q3
$1.79M Buy
30,177
+1,729
+6% +$114K 0.05% 306
2021
Q2
$1.9M Sell
28,448
-39,941
-58% -$2.6M 0.05% 300
2021
Q1
$3.64M Buy
+68,389
New +$4.26M 0.1% 190

Other funds holding BMY

Spire Wealth Management's BMY Position: Q2 2026 in Review

Spire Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 11% in Q2 2026, selling an estimated $42.6K and leaving 5,931 shares worth $342K. The position accounts for 0.01% of the portfolio, ranked #639.

Spire Wealth Management first reported a position in BMY in Q1 2021 and has held it in 22 quarters since. The position peaked at $3.64M in Q1 2021. 879 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Spire Wealth Management held 5,931 shares of Bristol-Myers Squibb worth $342K as of Q2 2026.
  • Spire Wealth Management sold 742 Bristol-Myers Squibb shares in Q2 2026, an estimated $42.6K.
  • Bristol-Myers Squibb made up 0.01% of Spire Wealth Management's portfolio in Q2 2026, its #639 holding.
  • Spire Wealth Management first reported a position in Bristol-Myers Squibb in Q1 2021 and has held it in 22 quarters since.
  • Spire Wealth Management's Bristol-Myers Squibb position peaked at $3.64M in Q1 2021.
  • 879 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.